Oral and Swallowing Abilities Tool (OrSAT) for Type 1 SMA Patients: Development of a New Module
- PMID: 34024771
- PMCID: PMC8385514
- DOI: 10.3233/JND-200614
Oral and Swallowing Abilities Tool (OrSAT) for Type 1 SMA Patients: Development of a New Module
Abstract
We describe the development of a new tool specifically designed to record oral abilities, swallowing and, more generally, feeding in young type 1 SMA patients, to be used during the first 24 months of life.The tool is composed by a checklist and a separate section summarizing the functional abilities into levels of feeding/swallowing impairment. The checklist includes 12 questions assessing aspects thought to be clinically meaningful for a type 1 SMA population and developmentally appropriate for infants during the first months of life. Each item is graded with a score of 0 or 1, depending on the child's ability to perform the activity. As some items are age-dependent, the number of items to be used, and therefore the maximum score, changes with increasing age. The levels of feeding/swallowing impairment include four levels that can be identified using easily identifiable clinical criteria.In an attempt to validate the tool in an untreated population we applied it to 24 type 1 SMA patients (age range: 2.3-24.1 months, mean: 10.8) in whom the same information collected by the new tool had been previously recorded using a less-structured format.When patients were classified in three groups according to the Dubowitz decimal classification, there was a significant difference both at baseline and at follow-up (p < 0.001). The items assessing fatigue during the nursing sessions were the most frequently impaired even in infants who did not have any other obvious clinical sign of swallowing difficulties.
Keywords: Spinal muscular atrophy; dysphagia; oral motor function; swallowing; type 1 SMA infants.
Conflict of interest statement
Eugenio Mercuri has received funding as a member of advisory boards for SMA studies for Scholar Rock, AveXis, Biogen, Ionis Pharmaceuticals, Inc., Novartis, and Roche; principal investigator for ongoing Ionis Pharmaceuticals, Scholar Rock, Inc./Biogen and Roche clinical trials; funding from Famiglie SMA Italy, Italian Telethon, and SMA Europe.
Giorgia Coratti received funding from Biogen, Roche, AveXis and Genesis Pharma as speaker in sponsored symposia.
Roberto de Sanctis received funding from Biogen as speaker in sponsored symposia.
Marika Pane received funding as a member of advisory boards from Biogen and AveXis and as speaker in sponsored symposia.
Richard S. Finkel Richard Finkel has received personal compensation for activities with Ionis Pharmaceuticals, Biogen, AveXis, Capricor, Catabasis, Lilly, Roche, Novartis; and the SMA Foundation, SMA Europe and Cure SMA as a consultant or advisor. Dr. Finkel has received research support from Ionis Pharmaceuticals, Biogen, Lilly, Cytokinetics Sarepta, NIH, MDA, and Summit.
Beatrice Berti, Lavinia Fanelli, Roberta Onesimo, Concetta Palermo, Daniela Leone, Sara Carnicella, Giulia Norcia, Nicola Forcina, Antonella Cerchiari, Valentina Giorgio, Simona Lucibello have nothing to disclose.
Figures
References
-
- Dubowitz V. Chaos in the classification of SMA: A possible resolution. Neuromuscul Disord. 1995;5(1):3–5. - PubMed
-
- De Sanctis R, Pane M, Coratti G, Palermo C, Leone D, Pera MC, et al.. Clinical phenotypes and trajectories of disease progression in type 1 spinal muscular atrophy. Neuromuscul Disord. 2018;28(1):24–8. - PubMed
-
- Finkel R, Bertini E, Muntoni F, Mercuri E, Group ESWS 209th ENMC International Workshop: Outcome Measures and Clinical Trial Readiness in Spinal Muscular Atrophy 7-9 November 2014, Heemskerk, The Netherlands. Neuromuscul Disord. 2015;25(7):593–602. - PubMed
-
- Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al.. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28(2):103–15. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
